by: Sherrie Conroy

A new class of point-of-care immunoassay platforms may reduce the time required to diagnose an array of medical conditions. These devices can deliver results at a level of accuracy previously available only in hospitals.

by: Yahia Gawad

With the variety of design methods, tools, operating systems, and architectures available for software development, the use of finite state logic may provide benefits along the path to FDA premarket approval.  

by: William Spees and Don Berndt

Improving the technology may be the key to reducing the number of heart attacks.

by: Sudhi Gautam and Arathi Asthi

Leveraging industry standards can help drive revenue for medical device manufacturers.

by: Ed McCauley

The agency’s tight-lipped addition of a new deputy director for science may be cause for concern.

by: Jim Dickinson

Bringing material research together with manufacturing expertise creates the perfect combination for a wide range of antimicrobial breakthroughs in medical tubing and device applications.

by: Marcia Coulson

A closer look at a recent recall shows a shift in FDA’s recall enforcement strategy.  

by: Bethany J. Hills and Monika Bhatt

by: Sherrie Conroy

by: Lawrence Lloyd

by: Heather Thompson

by: Heather Thompson

by: Heather Thompson

Meet the contributors to MD+DI's October issue.